<DOC>
	<DOCNO>NCT02974439</DOCNO>
	<brief_summary>This study evaluate pharmacokinetics bioequivalence Amlodipine Besylate Tablets 5 mg versus Norvasc 5 mg tablet administer 5 mg tablet healthy volunteer washout period 14 day</brief_summary>
	<brief_title>Bioequivalence Study Amlodipine Norvasc Under Fasting FED Conditions Chinese Healthy Volunteers</brief_title>
	<detailed_description>The study design Open-Label Randomized , Single-Dose , 2-way Crossover Bioequivalence Study washout period 14 day . During session , subject administer single dose 5mg amlodipine ( one LANDI-Amlodipine Tablet 5mg one Norvasc Tablet 5mg ) fast FED condition .</detailed_description>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . Healthy adult volunteer 1840 year old , male female . 2 . Body mass index ( BMI ) range 19.0 25.0 kg/m2 , body weight â‰¥ 50 kg male 45 kg female . 3 . No history heart , liver , kidney , gastrointestinal tract disease , nervous system , neural abnormities metabolic abnormality ; No preparation allergy , serious infection injury , etc . 4 . Medically healthy subject clinically normal laboratory profile ECGs . 5 . Subjects must agree take effective contraceptive method prevent pregnancy start screen 3 month last dose administration 6 . Subjects fully inform voluntarily consent participate study . 1 . History allergy hypersensitivity amlodipine 2 . Significant history neurological , cardiovascular , digestive , respiratory , urinary , hematological , dysmetabolism disease ( psychosis ) unfavorable study 3 . History postural hypotension 4 . Blood donation lose 400mL blood within 3 month prior study 5 . Use medication within 2 week study 6 . Volunteer clinical drug study within 3 month prior study 7 . Drug abuse alcohol abuse ( 220ml beer /day &gt; 5 time 2 hour ) 8 . Smoker ( &gt; 10 cigarettes/day ) 9 . A positive result hepatitis B surface antigen ( HBsAg ) , antihepatitis C virus ( HCV ) antibody , syphilis test , human immunodeficiency virus ( HIV ) test 10 . Abnormal chest Xray result clinical significance 11 . Women childbearing potential , pregnant lactate woman . 12 . Other unfavorable factor diagnose investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>